CoChat

Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis

Carino, Adriana, Marchianò, Silvia, Biagioli, Michele, Bucci, Mariarosaria, Vellecco, Valentina, Brancaleone, Vincenzo, Fiorucci, Chiara, Zampella, Angela, Monti, Maria Chiara, Distrutti, Eleonora, Fiorucci, Stefano · 2019 · The FASEB Journal
Cited by 56

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Nonalcoholic steatohepatitis (NASH) is associated with an increased risk of developing cardiovascular complications and mortality, suggesting that treatment of NASH might benefit from combined approaches that target the liver and the cardiovascular components of NASH. Using genetic and pharmacologic approaches, we show that G protein–coupled bile acid–activated receptor 1 (GPBAR1) agonism reverses liver and vascular damage in mouse models of NASH. NASH is associated with accelerated vascular inflammation representing an independent risk factor for development of cardiovascular diseases and cardiovascular‐related mortality. GPBAR1, also known as TGR5, is a G protein–coupled receptor for secondary bile acids that reduces inflammation and promotes energy expenditure. Using genetic and pharmacologic approaches, we investigated whether GPBAR1 agonism by 6β‐ethyl‐3α,7β‐dihydroxy‐5β‐cholan‐24‐ol (BAR501) reverses liver and vascular damage induced by exposure to a diet enriched in fat and fructose (HFD‐F). Treating HFD‐F mice with BAR501 reversed liver injury and promoted the browning of white adipose tissue in a Gpbar1‐dependent manner. Feeding HFD‐F resulted in vascular damage, as shown by the increased aorta intima‐media thickness and increased expression of inflammatory genes (IL‐6, TNF‐α, iNOS, and F4/80) and adhesion molecules (VCAM, intercellular adhesion molecule‐1, and endothelial selectin) in the aorta, while reducing the expression of genes involved in NO and hydrogen sulfide generation, severely altering vasomotor activities of aortic rings in an ex vivo assay. BAR501 reversed this pattern in a Gpbar1‐dependent manner, highlighting a potential role for GPBAR1 agonism in treating the liver and vascular component of NASH.—Carino, A., Marchianò, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., Fiorucci, S. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis. FASEB J. 33, 2809–2822 (2019). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201801373rr

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 56

Metadata

Authors
Carino, A., Marchianò, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., & Fiorucci, S.
Venue
The FASEB Journal
Publisher
Wiley
Published
2018-10-10
Volume
33
Issue
2
Pages
2809-2822
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2896736088
Cited by
56
References
19
FWCI
4.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.